Should Sponsors Cover 100% of Clinical Trial Costs? – An IRB Perspective
Author: Melissa Fink, Senior Director of IRB Operations, IRB Services In the United States, most clinical trials are conducted with funding provided by a government…
Author: Melissa Fink, Senior Director of IRB Operations, IRB Services In the United States, most clinical trials are conducted with funding provided by a government…
Author: Oleg Kisselev, IRB Chair As the number and complexity of clinical trials continue to grow, so does the imperative to ensure that participants are…
Author: Caitlyn Hauke, PhD, RBP, CBSP (ABSA) Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This…
Author: Caitlyn Hauke, Ph.D. Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the…
Authors: Garry Coulson, Ph.D. and Caitlyn Hauke, Ph.D. Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers….
Author: Caitlyn Hauke, Ph.D. Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the…
Author: Caitlyn Hauke, PhD, RBP, CBSP (ABSA) Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series…
A client needed to open 50 U.S. sites for a viral vector cancer vaccine study. Finding sites with the right expertise and facilities was going…
Sabai is proud to announce the consolidation of its subsidiary service lines—Castle IRB, CBS IBC and Shield Consulting—under one unified brand: Sabai Global. Now, all…
Introduction As routine handlers of highly dangerous biological materials and processes, laboratories throughout the biopharmaceutical manufacturing industry are required to possess strict emergency response protocols…
© 2025 Sabai
1-888-442-2472
[email protected]
16150 Main Circle Dr, Suite #100
Chesterfield, MO 63017